OTC: PMCUF - Pro Medicus Limited

Rentabilité sur six mois: +70.42%

Calendrier des promotions Pro Medicus Limited

Calendrier avancé Graphique simple
Financial Markets by TradingView

À propos de l'entreprise

Pro Medicus Limited, a healthcare informatics company, engages in the development and supply of healthcare imaging software, and radiology information (RIS) system software and services to hospitals, imaging centers, and health care groups in Australia, North America, and Europe. The company offers Visage RIS Visage 7 Enterprise Imaging Platform, a healthcare imaging software that provides radiologists, physicians, and clinicians with access and visualization capability for viewing 2-D, 3-D, and 4-D medical images; and picture archive and communication system (PACS)/digital imaging software.

plus de détails
It also provides Visage RIS, a proprietary medical software for practice management, training, installation, professional services, and after-sale support and service products; Promedicus.net, an e-health platform for secure email and integration products. In addition, the company offers Visage Ease Pro, a mobile application that provides users the ability to interpret various diagnostic imaging studies stored on a Visage 7 server. The company was incorporated in 1983 and is headquartered in Richmond, Australia.
Ajouter à la liste de comparaison
Ajouter à la liste de surveillance
Ajouter au portefeuille
Ajouter un avis de prix

Industry Health Care Technology
Sector Health Care
Валюта usd
Валюта отчета usd
Див.доход ао 0.4677
Дивиденд ао 0.2466
Сайт https://www.promed.com.au
Changement de prix par semaine: -3.53% (163.775)
Changement de prix par mois: +5.33% (150)
Changement de prix sur 3 mois: +31.67% (120)
Changement de prix sur six mois: +70.42% (92.71)
Changement de prix par an: +144.02% (64.75)
Evolution du prix sur 3 ans: +270.37% (42.66)
Evolution du prix sur 5 ans: +1 384.26% (10.645)
Evolution des prix depuis le début de l'année: -1.25% (160)
Tous les paramètres

Sous-estimation

Nom Signification Grade
P/S 92.7 1
P/BV 53.32 1
P/E 180.83 1
EV/EBITDA 123.33 1
Total: 1

Efficacité

Nom Signification Grade
ROA, % 28.2 8
ROE, % 39.47 9
Total: 9.33

Dividendes

Nom Signification Grade
Div yield, % 0.4464 1.13
DSI 0.9286 9.29
Total: 5.24

Devoir

Nom Signification Grade
Debt/EBITDA 0.025 10
Total: 9.6

Impulsion de croissance

Nom Signification Grade
Rentabilité Revenue, % 92.61 9
Rentabilité Ebitda, % 116.52 10
Rentabilité EPS, % 142.43 10
Total: 7.8
Plus de détails

Dividende, % Dividende Sur la base des résultats de la période Acheter avant Date de clôture du registre Paiement avant
0.24% 0.15 II кв. 2024 02.09.2024 04.09.2024 19.09.2024
0.19% 0.12 IV кв. 2023 27.02.2024 29.02.2024 15.03.2024
Plus de détails

Superviseur Titre d'emploi Paiement Année de naissance
Dr. Sam Aaron Hupert M.B.B.S., M.D. Co-Founder, CEO, MD & Executive Director 724.12k
Mr. Anthony Barry Hall B.Sc., B.Sc.(Hons), M.Sc. Co-Founder, Technology Director & Executive Director 251.94k
Mr. Clayton James Hatch B.Comm, CPA, CPA Chief Financial Officer 279.15k
Dr. Malte Westerhoff GM of Europe & Global CTO 822.73k
Mr. Brad Levin GM of North America & Global Head of Marketing 261.78k
Ms. Sharni L. Redenbach People & Culture Director N/A
Mr. Sean Lambright Global Head of Sales - Visage Imaging Inc 801.7k
Ms. Teresa Gschwind Global Head of Customer Service of Visage Imaging Inc. N/A
Ms. Danny English C.A. Financial Controller & Company Secretary N/A

Adresse: Australia, Richmond. VIC, 450 Swan Street - ouvrir dans Google Maps, ouvrir les cartes Yandex
Site web: https://www.promed.com.au